Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show strength in its portfolio with a significant backlog remaining and solid growth drivers, but the FY25 outlook will carry with it some questions as the year progresses, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
Questions or Comments about the article? Write to editor@tipranks.com